How Well Does Your Hospital Treat Bloodstream Infections?

Why Improving BSI Performance Benefits Your Patients and Your Bottom Line

As the Centers for Medicare & Medicaid Services (CMS) continues to transform from a passive payer to an active purchaser of higher-value health care services, hospitals need to adopt programs and strategies to improve patient outcomes and lower healthcare costs. Rapid diagnostics and quality antimicrobial stewardship can not only improve performance and reduce costs, it can improve patient outcomes. AdvanDx empowers  physicians by providing better clinical information for targeted therapy or discontinuation of expensive and unnecessary antibiotic use that can lead to adverse events or antimicrobial resistance.

Reduce Length of Stay and Antimicrobial Use1

Retrospective study of patients with Coagulase-Negative Staph + BCs


 Reduce Time to Appropriate Therapy2

 Retrospective study of patients with E. faecalis and E. faecium +BCs


Lower Hospital Costs Per Patient1

Retrospective study of patients with Coagulase-Negative Staph +BCs


The AdvanDx Solution

AdvanDx is a healthcare solutions company driven to ensure early, appropriate antibiotic therapy for patients with bloodstream infections. AdvanDx provides rapid pathogen identification that can help hospitals improve clinical outcomes for patients with bloodstream infections.  Clinical studies have shown that incorporating our PNA technology into hospitals led to 1) faster time to appropriate therapy, 2) shorter lengths of stay (LOS),  3) lower hospital costs per patient, 4) and reduction in antimicrobial use.1,2

Find out how the AdvanDx suite of rapid diagnostics can put your hospital on the front lines of effectively finding and treating critical bloodstream infections.

1) Forrest et al. J Antimicro Chemo 2006; 58(1):154-158.
2) Forrest et al. Antimicrob Agents Chemo 2008; 52(10):3558-3563.